MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2024 International Congress

    Exploring the Therapeutic Target for Lewy Body Disease using gba1 Knock-out Medaka

    E. Nakanishi, T. Taguchi, M. Sawamura, N. Uemura, H. Yamakado, R. Takahashi (kyoto, Japan)

    Objective: This study was performed to explore the therapeutic target for Lewy body disease. Background: Lewy body disease (LBD), including Parkinson's disease and diffuse Lewy…
  • 2024 International Congress

    Rationale for LRRK2 inhibition in sporadic Parkinson’s disease and the LUMA trial

    R. Hauser, A. Lang, L. Kalia, JT. Greenamyre, R. Llorens-Arenas, D. Jennings, B. Hersh, K. Fraser, S. Huntwork-Rodriguez, A. Henry, J. Kluss, C. Paisán-Ruiz, Z. Berger (Tampa, USA)

    Objective: To summarize the rationale for LRRK2 inhibition in sporadic PD patients without LRRK2 mutations, and to describe the current design of the LUMA study,…
  • 2024 International Congress

    Declining Lymphocyte Count and Lymphocyte-to-Neutrophil Ratio Following Parkinson’s Disease Diagnosis.

    J. Kenny, R. Torricelli, A. Zirra, A. Noyce, D. Gallagher, T. Periñán, C. Budu, T. Boyle, KC. Dey (London, United Kingdom)

    Objective: To replicate previous findings in a diverse East London population, further characterising changes in FBC constituents and evaluating their temporal association with PD diagnosis.…
  • 2024 International Congress

    Reaching Kinematics in Movement Disorder Patients Using an Open-Source Computer Vision Technology

    AB. Bayen, S. Majumdar, S. Choudhury, J. Ganguly, P. Basu, S. Dey, M. Baker, S. Baker, H. Kumar (Kolkata, India)

    Objective: In this study, we compared kinematic parameters of reaching task between SCA12 and healthy control participants using a novel tracking device. Background: Reaching for…
  • 2024 International Congress

    Alterations of NAD metabolism in symptomatic and asymptomatic carriers of pathogenic GCH1 variant

    J. Prasuhn, L. van Well, F. Hamami, C. Klein, A. Weissbach, N. Brüggemann (Lübeck, Germany)

    Objective: To investigate whether carriers of pathogenic GCH1 variant reveal lower NAD levels in the basal ganglia or the cerebellum compared to variant-free controls. Background:…
  • 2024 International Congress

    White matter abnormalities in motor subtypes of Parkinson’s disease

    S. Prasad, T. Nagaraj, S. Bhat, S. Purushotham, R. Taneja, V. Holla, R. Mahale, N. Kamble, R. Yadav, J. Saini, P. Pal (Bengaluru, India)

    Objective: To evaluate white matter microstructural integrity in Tremor dominant Parkinson’s disease (TDPD) and postural instability and gait disturbance (PIGD) subtypes of PD to ascertain…
  • 2024 International Congress

    Longitudinal change in brain function and structure related to plasma neurofilament light protein in early-stage Parkinson’s disease

    Y. Xiao, SC. Wang, YB. Hou, HF. Shang (Chengdu, China)

    Objective: We aimed to explore the relationship between the pNfL and change in the brain in early-stage PD using a longitudinal brain imaging cohort. Background:…
  • 2024 International Congress

    Differential Diagnosis of Parkinsonism with 18F-FP-CIT PET using a Self-supervised Deep Learning Model

    GY. Lee, J. Won, S. Jo, J. Lee, S. Lee, N. Kim, SJ. Chung (Seoul, Republic of Korea)

    Objective: To develop a self-supervised deep learning model using 18F-FP-CIT PET images from patients with Parkinsonism and to evaluate the model’s performance in the differential…
  • 2024 International Congress

    Cholinergic brain vulnerabilities associate with diabetic comorbidity in Parkinson disease

    G. Carli, P. Kanel, T. Brown, S. Roytman, R. Albin, N. Bohnen (Ann Arbor, USA)

    Objective: We aim to explore differences in brain cholinergic nerve terminal integrity between Parkinson's disease (PD) patients with and without comorbid diabetes, utilizing a highly…
  • 2024 International Congress

    Enlarged Perivascular Spaces in the Temporal Lobe as a Predictor for Incident Dementia in Parkinson’s Disease

    HK. Na, Y. Sun, JH. Lee, CW. Park, YH. Sohn, CH. Lyoo, PH. Lee (Seoul, Republic of Korea)

    Objective: To evaluate the whether regional burden of enlarged perivascular space (EPVS) hold prognostic value in predicting the dementia conversion in Parkinson's disease (PD). Background:…
  • « Previous Page
  • 1
  • …
  • 162
  • 163
  • 164
  • 165
  • 166
  • …
  • 181
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley